These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35682717)

  • 1. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.
    Li Y; Ricardo SD; Samuel CS
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
    Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
    Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice.
    Li Y; Zheng G; Salimova E; Broughton BRS; Ricardo SD; de Veer M; Samuel CS
    Biomed Pharmacother; 2023 Feb; 158():114069. PubMed ID: 36502754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension.
    Li Y; Shen M; Ferens D; Broughton BRS; Murthi P; Saini S; Widdop RE; Ricardo SD; Pinar AA; Samuel CS
    Br J Pharmacol; 2021 Mar; 178(5):1164-1181. PubMed ID: 33450051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease.
    Oka M; Kameishi S; Cho YK; Song SU; Grainger DW; Okano T
    Tissue Eng Part C Methods; 2023 Feb; 29(2):54-62. PubMed ID: 36719774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem-cells' exosomes are renoprotective in postmenopausal chronic kidney injury via reducing inflammation and degeneration.
    Alasmari WA; El-Shetry ES; Ibrahim D; ElSawy NA; Eldoumani H; Metwally AS; Saleh AA; Mona MM; Abd-Elsalam MM; Hendam BM; Essawi WM; Abourehab MAS; Abdelfattah-Hassan A
    Free Radic Biol Med; 2022 Mar; 182():150-159. PubMed ID: 35218913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
    Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
    FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
    Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
    Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes Derived from BM-MSCs Mitigate the Development of Chronic Kidney Damage Post-Menopause via Interfering with Fibrosis and Apoptosis.
    Alasmari WA; Abdelfattah-Hassan A; El-Ghazali HM; Abdo SA; Ibrahim D; ElSawy NA; El-Shetry ES; Saleh AA; Abourehab MAS; Mahfouz H
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease.
    van Rhijn-Brouwer FCC; van Balkom BWM; Papazova DA; Hazenbrink DHM; Meijer AJ; Brete I; Briceno V; van Zuilen AD; Toorop RJ; Fledderus JO; Gremmels H; Verhaar MC
    Stem Cells Int; 2019; 2019():1232810. PubMed ID: 31933648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.
    Yoon YM; Lee JH; Song KH; Noh H; Lee SH
    J Pineal Res; 2020 Apr; 68(3):e12632. PubMed ID: 31989677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.
    Royce SG; Tominaga AM; Shen M; Patel KP; Huuskes BM; Lim R; Ricardo SD; Samuel CS
    Clin Sci (Lond); 2016 Dec; 130(23):2151-2165. PubMed ID: 27647937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.
    Zhang L; Lai X; Guo Y; Ma J; Fang J; Li G; Xu L; Yin W; Chen Z
    Ren Fail; 2021 Dec; 43(1):1266-1275. PubMed ID: 34493167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous transplantation of mesenchymal stromal cells tends to prevent progress of interstitial fibrosis in a rhesus Macaca mulatta monkey model of chronic kidney disease.
    Moghadasali R; Hajinasrollah M; Argani H; Nassiri SM; Najarasl M; Sodeifi N; Baharvand H; Aghdami N
    Cytotherapy; 2015 Nov; 17(11):1495-505. PubMed ID: 26341479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
    Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model.
    Wang X; Wang H; Lu J; Feng Z; Liu Z; Song H; Wang H; Zhou Y; Xu J
    Tissue Eng Regen Med; 2020 Oct; 17(5):683-693. PubMed ID: 32621283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
    Ringdén O; Moll G; Gustafsson B; Sadeghi B
    Front Immunol; 2022; 13():839844. PubMed ID: 35371003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BM-MSCs from Wuzhishan mini-pigs delay the progress of renal fibrosis induced by chronic kidney disease through 
autocrine hepatocyte growth factor in vitro].
    Xiang Y; Long J; Xing J; Gao Y; Cheng Q; Cai Y; Liu Z; Zhang S; Chen L; Yang C; Bai Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1260-1269. PubMed ID: 28070037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells.
    Kim H; Yu MR; Lee H; Kwon SH; Jeon JS; Han DC; Noh H
    Aging Cell; 2021 Feb; 20(2):e13317. PubMed ID: 33524231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.